PD-L1– and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease
570
Anti-Glomerular Basement Membrane Disease
Injections, Subcutaneous
610
Autoimmunity
CHO Cells
Mouse models
B7-H1 Antigen
Arthritis, Rheumatoid
03 medical and health sciences
Cricetulus
0302 clinical medicine
Calcitriol
Antigen presenting cells
Immune Tolerance
Animals
Humans
Antigen Presentation
Immunodominant Epitopes
Cell Differentiation
Dendritic Cells
HLA-DR Antigens
Adoptive Transfer
3. Good health
Disease Models, Animal
2700 Medicine
Nephrology
Liposomes
Female
Tolerance
Immunologic Memory
DOI:
10.1172/jci.insight.126025
Publication Date:
2019-09-05T16:00:36Z
AUTHORS (27)
ABSTRACT
Autoimmune diseases resulting from MHC class II–restricted autoantigen-specific T cell immunity include the systemic inflammatory autoimmune conditions rheumatoid arthritis and vasculitis. While currently treated with broad-acting immunosuppressive drugs, a preferable strategy is to regulate antigen-specific effector cells (Teffs) restore tolerance by exploiting DC antigen presentation. We targeted draining lymph node (dLN) phagocytic DCs using liposomes encapsulating 1α,25-dihydroxyvitamin D3 (calcitriol) antigenic peptide elucidate mechanisms of used responding under resting immunized conditions. PD-L1 expression was upregulated in dLNs relative naive mice. Subcutaneous administration OVA323–339 calcitriol dLN PD-L1hi mice reduced their II expression. OVA323–339/calcitriol suppressed expansion, differentiation, function Teffs induced Foxp3+ IL-10+ peripheral Tregs an manner, which dependent on PD-L1. Peptide/calcitriol modulated CD40 human promoted Treg induction vitro. Liposomes disease-associated peptides severity Goodpasture's vasculitis models suppression memory differentiation function. Accordingly, peptide/calcitriol leverage for regulation induce diseases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (70)
CITATIONS (54)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....